- 全部删除
- 您的购物车当前为空
MPT0E028 is an orally active and selective inhibitor of HDAC (IC50s of 53.0 nM, 106.2 nM, 29.5 nM for HDAC1, HDAC2, and HDAC6, respectively). MPT0E028 has good anticancer activity. MPT0E028 decreases the viability of B-cell lymphomas by inducing apoptosis and possesses potent direct Akt targeting ability and reduces Akt phosphorylation in B-cell lymphoma.
为众多的药物研发团队赋能,
让新药发现更简单!
MPT0E028 is an orally active and selective inhibitor of HDAC (IC50s of 53.0 nM, 106.2 nM, 29.5 nM for HDAC1, HDAC2, and HDAC6, respectively). MPT0E028 has good anticancer activity. MPT0E028 decreases the viability of B-cell lymphomas by inducing apoptosis and possesses potent direct Akt targeting ability and reduces Akt phosphorylation in B-cell lymphoma.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 1,270 | 5日内发货 | |
5 mg | ¥ 2,350 | 5日内发货 | |
25 mg | ¥ 8,160 | 6-8周 | |
50 mg | ¥ 10,600 | 6-8周 | |
100 mg | ¥ 16,500 | 6-8周 |
产品描述 | MPT0E028 is an orally active and selective inhibitor of HDAC (IC50s of 53.0 nM, 106.2 nM, 29.5 nM for HDAC1, HDAC2, and HDAC6, respectively). MPT0E028 has good anticancer activity. MPT0E028 decreases the viability of B-cell lymphomas by inducing apoptosis and possesses potent direct Akt targeting ability and reduces Akt phosphorylation in B-cell lymphoma. |
靶点活性 | HDAC8:2532.6 nM, HDAC6:29.5 nM, HDAC1:53.0 nM, Akt:, HDAC2:106.2 nM |
分子量 | 344.38 |
分子式 | C17H16N2O4S |
CAS No. | 1338320-94-7 |
密度 | 1.427 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容